The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by ...

CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, emphasizing recovery in ...

CVS Health Corp issued an optimistic guidance for 2025 stemming from the expected recovery in its insurance business — ...

CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

Sees FY25 free cash flow $6.5B. The company said, “The Company issued its full-year 2025 GAAP diluted EPS guidance range of $4.58 to $4.83 and ...

Reports Q4 revenue $97.7B, consensus $96.88B. The company said, “Our integrated model allows us to uniquely deliver a simpler, connected ...

Shares of CVS Health surged in premarket trading Wednesday after the health insurance and pharmacy giant reported better-than-expected fourth-quarter results.

What Happened? Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 16.4% in the morning session after the ...

Shares of CVS Health Corp. were having their best day in 26 years on Wednesday, after the drugstore chain and healthcare-services company beat quarterly profit expectations by a wide margin, and as ...

Diversified healthcare company CVS Health (NYSE:CVS) announced in Q4 CY2024, with sales up 4.2% year on year to $97.71 ...

CVS Health reported Q4 2024 profits of $1.6 billion, down from $2 billion, with annual profits at $4.6 billion, down $8.3 billion in 2023.

U.S. stock futures are little changed as investors watch for January inflation data, and Fed Chair Jerome Powell is set to ...